GREEN CROSS LAB CELL
GC Green Cross Their goal is to contribute to the healthy life of mankind and become a global leader in the healthcare industry. Recent advances in biotechnology have become a good foundation for achieving their goals. The paradigm of medicine is changing. They are shifting from traditional medicines and synthetic medicines to biopharmaceutical development. GC Green Cross Cellular gene therapy, which is the main pipeline of LAPSEL, is expected to enable the treatment of rare and intractable dis... eases as well as cancer, because of the fundamental treatment of diseases at the gene and cell level. In particular, successful cases such as approval of the first immunotherapeutic drug (CAR-T) in 2017 and the approval of the first gene therapy (Luxturna) were epoch-making events that transformed the expectations they had in mind into reality. Is added.
GREEN CROSS LAB CELL
Industry:
Biotechnology
Status:
Active
Contact:
82 3 1260 9600
Technology used in webpage:
Apache Korea Telecom
Similar Organizations
Lutris Pharma
Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-07-16 | GC Cell | GC Cell acquired by Green Cross Lab Cell | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-02-26 | Artiva Biotherapeutics | Green Cross Lab Cell investment in Series B - Artiva Biotherapeutics | 120 M USD |
2020-06-26 | Artiva Biotherapeutics | Green Cross Lab Cell investment in Series A - Artiva Biotherapeutics | 78 M USD |
More informations about "Green Cross Lab Cell"
Green Cross Lab Cell - Crunchbase Investor Profile
Development. GC Green Cross Cellular gene therapy, which is the main pipeline of LAPSEL, is expected to enable the treatment of rare and intractable diseases as well as cancer, because of the fundamental treatment of diseases at the โฆSee details»
Green Cross Lab Cell and C&R Research Signs Joint โฆ
Oct 30, 2019 GCCL will be a subsidiary of GC Lab Cell, with GC Lab Cell and C&R Research as its major shareholders of 67% and 26.1%, respectively. GCCL will serve as a central laboratory that analyzes biosamples (human biologicals โฆSee details»
KOREA LIFE SCIENCE WEEK
GC Cell was reborn as joint corporation of Koreaโs leading cell therapy companies, GC Green Cross Cell and GC Green Cross Lab Cell, for a new leap forward. GC Cell is leading the โฆSee details»
Green Cross LabCell Corporation (GC LabCell) (KRX: 114510)
Its subsidiary, Green Cross LabCell is focused on clinical development of MG4101, a random donor PBMC-derived, ex vivo expanded and activated NK cell product in a number of Phase II โฆSee details»
Green Cross Lab Cell - Investments, Portfolio & Company Exits
Green Cross Lab Cell has acquired GC Cell on Jul 16, 2021. Unlock for free . Investments. Edit Investments Section. Number of Investments 2. Green Cross Lab Cell has made 2 โฆSee details»
Green Cross Lab Cell Corporation entered into a definitive merger ...
Jul 15, 2021 Green Cross Lab Cell Corporation (KOSDAQ:A144510) entered into a definitive merger agreement to acquire Green Cross Cell Corporation (KOSDAQ:A031390) from a group โฆSee details»
GC Cell Corporation Stock - MarketScreener.com
Nov 22, 2024 GC Cell Corp formerly Green Cross Lab Cell Corp is a Korea-based company principally engaged in the provision of specimen testing services. The Company operates its โฆSee details»
Green Cross Lab Cell acquires GC Cell - 2021-07-16 - Crunchbase
Jul 16, 2021 GC Cell GC Cell specialize in cell therapy, obtained approval for its developed Immunecell-LC as a liver cancer immunotherapy agent in 2007. Acquiring Organization: Green โฆSee details»
Green Cross Lab Cell Corporation completed the acquisition of โฆ
Oct 26, 2021 Green Cross Lab Cell Corporation entered into a definitive merger agreement to acquire Green Cross Cell Corporation from a group of shareholders for approximately KRW โฆSee details»
Grifols to acquire Green Cross plasma fractionation facility in ...
Jul 20, 2020 The volumetric proportion of red blood cells in the blood. This value is obtained by performing a blood test in a laboratory. The normal hematocrit values depend on the โฆSee details»
Green Cross Lab Cell - Funding, Financials, Valuation & Investors
Green Cross Lab Cell Corporation develops cell therapy products.See details»
Green Cross Labcell joins US$1.8 bln deal to develop cancer drug
SEOUL, Jan. 29 (Yonhap) -- A subsidiary of South Korean pharmaceutical firm Green Cross Corp. said Friday it has participated in a partnership deal worth US$1.8 billion to develop โฆSee details»
LABORATORY CORPORATION OF AMERICA NPI 1205272622 โฆ
May 13, 2013 NPI Profile for Laboratory Corporation Of America in 2022 Opitz Blvd Woodbridge, Va 22191. Phone: (703) 707-2262 . Taxonomy 291U00000X Accepts: Blue Cross and Blue โฆSee details»
Grifols closes the acquisition of Green Cross fractionation plant in ...
Oct 1, 2020 The volumetric proportion of red blood cells in the blood. This value is obtained by performing a blood test in a laboratory. The normal hematocrit values depend on the โฆSee details»
Schedule Pickup - GreenDrop
GreenDrop makes it convenient to donate your lightly used clothing, household items and other goods to a nonprofit with our free home donation pickup program. Schedule now!See details»
Green Cross Lab Cell Corporation completed the acquisition of โฆ
Oct 26, 2021 Green Cross Lab Cell Corporation (KOSDAQ:A144510) entered into a definitive merger agreement to acquire Green Cross Cell Corporation (KOSDAQ:A031390) from a group โฆSee details»
Find a Plasma Donation Center | Donate Plasma to Red Cross
During a plasma-only donation, blood is drawn from one arm and sent through a high-tech machine that collects your plasma and then safely and comfortably returns your red cells and โฆSee details»
SubCellBarCode: Proteome-wide Mapping of Protein ... - Cell Press
Jan 3, 2019 Orre et al. use mass spectrometry to map the subcellular localization of more than 12,000 proteins across several cell lines and present a method for proteome-wide โฆSee details»
Kleo Pharmaceuticals Enters into Research Collaboration with โฆ
Mar 31, 2020 Green Cross Lab Cell Corporation completed the acquisition of Green Cross Cell Corporation from a group of shareholders. 21-10-26: CI Green Cross Lab Cell Corporation โฆSee details»